Drug or technology

Petrelintide

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · PHASE 2 TRIAL

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

ClinicalTrials.gov

Phase 2 trial with completed enrollment but no results posted; design and primary outcome are specified but efficacy and safety data are not yet reported in this registry record.

PreliminaryNCT06926842 Obesity Overweight

Reported

Planned enrollment221

Study phasePhase 2

Primary outcome measurePercentage Change in Body Weight, From Base…

AUG 7, 2026 · PHASE 2 TRIAL

A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight

ClinicalTrials.gov

This is a planned Phase 2 dose-finding trial with no results yet reported; registration documents the study design and population but carries no efficacy or safety data.

PreliminaryPetrelintide Enicepatide-matching Placebo NCT07589686

Reported

Planned enrollment486

PhasePhase 2

Primary endpointPercentage change in body weight between Ar…